Lv1
70 积分 2024-12-08 加入
Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma
1天前
已完结
Superficial CD34-Positive Fibroblastic Tumor
1个月前
已完结
Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients
3个月前
已完结
Diffuse bone and soft tissue angiomatosis with GNAQ mutation
4个月前
已关闭
皖公网安备34019202002308
